HLA-A*2402 CMV pp65 Tetramer-QYDPVAALF-PE

MBL Life Sciences

Catalog No.: MBL-TS-0020-1C

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: PE
• Immunogen: CMV pp65
• Peptide Sequence: QYDPVAALF
• Class: Class I
• Sequence Location: 341-349
• MHC Allele: A*24:02

Citations for HLA-A*2402 CMV pp65 Tetramer-QYDPVAALF-PE – 1 Found

Watanabe, Kazue; Suzuki, Susumu; Kamei, Michi; Toji, Shingo; Kawase, Takakazu; Takahashi, Toshitada; Kuzushima, Kiyotaka; Akatsuka, Yoshiki. CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. International Journal Of Hematology. 2008;88(3):311-320.